Mathias W. R. Pletz
Department of International Health
Rollins School of Public Health
Emory University
1518 Clifton Rd.
USA
Name/email consistency: high
- Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy. Pletz, M.W., McGee, L., Burkhardt, O., Lode, H., Klugman, K.P. Eur. J. Clin. Microbiol. Infect. Dis. (2005)
- Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States. Pletz, M.W., McGee, L., Beall, B., Whitney, C.G., Klugman, K.P. Antimicrob. Agents Chemother. (2005)
- Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study. Pletz, M.W., De Roux, A., Roth, A., Neumann, K.H., Mauch, H., Lode, H. Antimicrob. Agents Chemother. (2004)
- Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Pletz, M.W., McGee, L., Jorgensen, J., Beall, B., Facklam, R.R., Whitney, C.G., Klugman, K.P. Antimicrob. Agents Chemother. (2004)
- Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Pletz, M.W., Rau, M., Bulitta, J., De Roux, A., Burkhardt, O., Kruse, G., Kurowski, M., Nord, C.E., Lode, H. Antimicrob. Agents Chemother. (2004)